Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common stock, par value $0.00001 per share
-
Shares outstanding
-
52,942,731
-
Number of holders
-
91
-
Total 13F shares, excl. options
-
43,990,444
-
Shares change
-
+1,749,216
-
Total reported value, excl. options
-
$1,310,907,931
-
Value change
-
+$46,789,977
-
Number of buys
-
49
-
Number of sells
-
-33
-
Price
-
$29.80
Significant Holders of PMV Pharmaceuticals, Inc. - Common stock, par value $0.00001 per share (PMVP) as of Q3 2021
99 filings reported holding PMVP - PMV Pharmaceuticals, Inc. - Common stock, par value $0.00001 per share as of Q3 2021.
PMV Pharmaceuticals, Inc. - Common stock, par value $0.00001 per share (PMVP) has 91 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 43,990,444 shares
of 52,942,731 outstanding shares and own 83.1% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (7,330,423 shares), INTERWEST VENTURE MANAGEMENT CO (3,869,911 shares), Avoro Capital Advisors LLC (2,925,000 shares), Euclidean Capital LLC (2,769,813 shares), VANGUARD GROUP INC (2,653,394 shares), BOXER CAPITAL, LLC (2,268,236 shares), BlackRock Inc. (2,187,923 shares), STATE STREET CORP (1,818,342 shares), JPMORGAN CHASE & CO (1,807,092 shares), and VIKING GLOBAL INVESTORS LP (1,790,284 shares).
This table shows the top 91 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.